Last Updated On 3/13/2023 12:13:52 AM
This is a disclosure report of the user financial relationships with for-profit health care companies.
All relationships are considered compensated unless otherwise noted. Relationships are self-held unless otherwise noted.
Employment |
No Relationships to Disclose |
|
|
Leadership |
No Relationships to Disclose |
|
|
Stock and Other Ownership Interests |
No Relationships to Disclose |
|
|
Honoraria |
No Relationships to Disclose |
|
|
Consulting or Advisory Role |
Company: Exelixis |
Recipient: You |
Company: Merck |
Recipient: You |
Company: QED Therapeutics |
Recipient: You |
Company: Incyte |
Recipient: You |
Company: Astra Zeneca |
Recipient: You |
Company: Taiho Pharmaceutical |
Recipient: You |
Company: Boehringer Ingelheim |
Recipient: You |
Company: SERVIER |
Recipient: You |
Company: Genentech |
Recipient: You |
Company: Basilea |
Recipient: You |
|
Speakers' Bureau |
No Relationships to Disclose |
|
|
Research Funding |
Company: Pieris Pharmaceuticals |
Recipient: You |
Company: Taiho Pharmaceutical |
Recipient: You |
Company: Merck |
Recipient: You |
Company: Exelixis |
Recipient: You |
Company: QED Therapeutics |
Recipient: You |
Company: Rafael Pharmaceuticals |
Recipient: You |
Company: Bristol-Myers Squibb |
Recipient: You |
Company: Bayer |
Recipient: You |
Company: Immunovaccine |
Recipient: You |
Company: Seagen |
Recipient: You |
Company: Novocure |
Recipient: You |
Company: Nucana |
Recipient: You |
Company: Loxo/Lilly |
Recipient: You |
Company: Faeth Therapeutics |
Recipient: You |
Company: NGM Biopharmaceuticals |
Recipient: You |
|
Patents, Royalties, Other Intellectual Property |
No Relationships to Disclose |
|
|
Expert Testimony |
No Relationships to Disclose |
|
|
Travel, Accommodations, Expenses |
No Relationships to Disclose |
|
|
Other Relationship |
No Relationships to Disclose |
|
|
(OPTIONAL) Uncompensated Relationships |
No Relationships to Disclose |
|
|
(OPTIONAL) Open Payments Link |
No Relationships to Disclose |
|
|